nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—Clofarabine—hematologic cancer	0.158	0.221	CbGbCtD
Hydroxyurea—RRM1—Clofarabine—hematologic cancer	0.158	0.221	CbGbCtD
Hydroxyurea—RRM1—Fludarabine—hematologic cancer	0.12	0.167	CbGbCtD
Hydroxyurea—RRM2—Cladribine—hematologic cancer	0.0771	0.108	CbGbCtD
Hydroxyurea—RRM1—Cladribine—hematologic cancer	0.0771	0.108	CbGbCtD
Hydroxyurea—RRM1—Gemcitabine—hematologic cancer	0.0497	0.0695	CbGbCtD
Hydroxyurea—RRM2—Gemcitabine—hematologic cancer	0.0497	0.0695	CbGbCtD
Hydroxyurea—CYP2D6—Lomustine—hematologic cancer	0.00565	0.00791	CbGbCtD
Hydroxyurea—CYP2D6—Idarubicin—hematologic cancer	0.00504	0.00705	CbGbCtD
Hydroxyurea—CYP2D6—Bortezomib—hematologic cancer	0.00373	0.00522	CbGbCtD
Hydroxyurea—RRM2—hematopoietic system—hematologic cancer	0.00277	0.112	CbGeAlD
Hydroxyurea—CYP2D6—Imatinib—hematologic cancer	0.00273	0.00382	CbGbCtD
Hydroxyurea—CYP2D6—Nilotinib—hematologic cancer	0.00248	0.00347	CbGbCtD
Hydroxyurea—CYP2D6—Vinorelbine—hematologic cancer	0.00246	0.00344	CbGbCtD
Hydroxyurea—RRM1—hematopoietic system—hematologic cancer	0.00231	0.0928	CbGeAlD
Hydroxyurea—RRM2—gonad—hematologic cancer	0.00211	0.085	CbGeAlD
Hydroxyurea—RRM2—blood—hematologic cancer	0.00184	0.074	CbGeAlD
Hydroxyurea—RRM2—bone marrow—hematologic cancer	0.00178	0.0716	CbGeAlD
Hydroxyurea—RRM1—gonad—hematologic cancer	0.00175	0.0706	CbGeAlD
Hydroxyurea—RRM2—lung—hematologic cancer	0.00161	0.0649	CbGeAlD
Hydroxyurea—RRM1—blood—hematologic cancer	0.00153	0.0615	CbGeAlD
Hydroxyurea—RRM2—testis—hematologic cancer	0.00152	0.0612	CbGeAlD
Hydroxyurea—CYP2D6—Vinblastine—hematologic cancer	0.00152	0.00212	CbGbCtD
Hydroxyurea—RRM1—bone marrow—hematologic cancer	0.00148	0.0595	CbGeAlD
Hydroxyurea—RRM1—lung—hematologic cancer	0.00134	0.0539	CbGeAlD
Hydroxyurea—RRM1—testis—hematologic cancer	0.00126	0.0509	CbGeAlD
Hydroxyurea—CYP2D6—Dexamethasone—hematologic cancer	0.00112	0.00157	CbGbCtD
Hydroxyurea—RRM2—lymph node—hematologic cancer	0.0011	0.0444	CbGeAlD
Hydroxyurea—CYP2D6—Doxorubicin—hematologic cancer	0.000931	0.0013	CbGbCtD
Hydroxyurea—RRM1—lymph node—hematologic cancer	0.000916	0.0369	CbGeAlD
Hydroxyurea—CYP2D6—hematopoietic system—hematologic cancer	0.000685	0.0276	CbGeAlD
Hydroxyurea—CYP2D6—blood—hematologic cancer	0.000454	0.0183	CbGeAlD
Hydroxyurea—CYP2D6—testis—hematologic cancer	0.000375	0.0151	CbGeAlD
Hydroxyurea—RRM1—Azacitidine—Pentostatin—hematologic cancer	0.000298	0.0959	CbGdCrCtD
Hydroxyurea—RRM2—Vinorelbine—Vinblastine—hematologic cancer	0.000287	0.0924	CbGdCrCtD
Hydroxyurea—RRM2—Vinorelbine—Vincristine—hematologic cancer	0.000287	0.0924	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Clofarabine—hematologic cancer	0.000266	0.0855	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Nelarabine—hematologic cancer	0.00025	0.0804	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Fludarabine—hematologic cancer	0.000195	0.0627	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Pentostatin—hematologic cancer	0.000187	0.0602	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Cytarabine—hematologic cancer	0.000184	0.0593	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—hematologic cancer	0.000184	0.0593	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Cladribine—hematologic cancer	0.00018	0.0577	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Clofarabine—hematologic cancer	0.000167	0.0537	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Nelarabine—hematologic cancer	0.000157	0.0505	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Fludarabine—hematologic cancer	0.000123	0.0394	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—hematologic cancer	0.000116	0.0372	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Cytarabine—hematologic cancer	0.000116	0.0372	CbGdCrCtD
Hydroxyurea—RRM2—Azacitidine—Cladribine—hematologic cancer	0.000113	0.0363	CbGdCrCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	8.48e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	8.46e-05	0.00142	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND3—hematologic cancer	8.44e-05	0.00141	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—CDKN1A—hematologic cancer	8.2e-05	0.00137	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	8.14e-05	0.00136	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	8.12e-05	0.00136	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CDA—hematologic cancer	8.11e-05	0.00136	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	8.06e-05	0.00135	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—NUP98—hematologic cancer	8.04e-05	0.00135	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PC—hematologic cancer	7.81e-05	0.00131	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—NUP214—hematologic cancer	7.75e-05	0.0013	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—DCK—hematologic cancer	7.7e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—B3GAT1—hematologic cancer	7.7e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ASNS—hematologic cancer	7.7e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	7.66e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—SMC1A—hematologic cancer	7.64e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TOP2A—hematologic cancer	7.57e-05	0.00127	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	7.55e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC35B2—hematologic cancer	7.54e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GBA—hematologic cancer	7.54e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—H3F3A—hematologic cancer	7.49e-05	0.00126	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	7.49e-05	0.00125	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HDC—hematologic cancer	7.3e-05	0.00122	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—hematologic cancer	7.14e-05	0.0012	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MLH1—hematologic cancer	7.14e-05	0.0012	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK6—hematologic cancer	7.03e-05	0.00118	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—SLC35B2—hematologic cancer	6.92e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	6.91e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTAP—hematologic cancer	6.9e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	6.89e-05	0.00115	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—SMC1A—hematologic cancer	6.83e-05	0.00115	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—EPHX1—hematologic cancer	6.82e-05	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—hematologic cancer	6.8e-05	0.00114	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TOP2A—hematologic cancer	6.77e-05	0.00113	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	6.75e-05	0.00113	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—H3F3A—hematologic cancer	6.7e-05	0.00112	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	6.69e-05	0.00112	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CDA—hematologic cancer	6.68e-05	0.00112	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	6.57e-05	0.0011	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	6.56e-05	0.0011	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PC—hematologic cancer	6.43e-05	0.00108	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	6.36e-05	0.00107	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	6.34e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	6.31e-05	0.00106	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK6—hematologic cancer	6.29e-05	0.00105	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC35B2—hematologic cancer	6.21e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GBA—hematologic cancer	6.21e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	6.21e-05	0.00104	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—FHL2—hematologic cancer	6.15e-05	0.00103	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	6.05e-05	0.00101	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND2—hematologic cancer	6.05e-05	0.00101	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AGRN—hematologic cancer	6.03e-05	0.00101	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.88e-05	0.000986	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—hematologic cancer	5.73e-05	0.00096	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	5.73e-05	0.00096	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HMMR—hematologic cancer	5.71e-05	0.000957	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—IDH2—hematologic cancer	5.71e-05	0.000957	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTAP—hematologic cancer	5.68e-05	0.000951	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—HSP90AA1—hematologic cancer	5.64e-05	0.000945	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	5.42e-05	0.000909	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	5.42e-05	0.000908	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND2—hematologic cancer	5.41e-05	0.000906	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ARNTL—hematologic cancer	5.37e-05	0.0009	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	5.27e-05	0.000883	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	5.26e-05	0.000881	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CA9—hematologic cancer	5.23e-05	0.000876	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ACP5—hematologic cancer	5.23e-05	0.000876	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOR2—hematologic cancer	5.16e-05	0.000864	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—FHL2—hematologic cancer	5.06e-05	0.000848	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AGRN—hematologic cancer	4.96e-05	0.000832	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—IDH1—hematologic cancer	4.91e-05	0.000823	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.91e-05	0.000823	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.87e-05	0.000816	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTO1—hematologic cancer	4.86e-05	0.000814	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—TXN—hematologic cancer	4.86e-05	0.000814	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCC3—hematologic cancer	4.86e-05	0.000814	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2B—hematologic cancer	4.85e-05	0.000812	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SPHK1—hematologic cancer	4.75e-05	0.000797	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH2—hematologic cancer	4.71e-05	0.000788	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HMMR—hematologic cancer	4.71e-05	0.000788	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—BIRC5—hematologic cancer	4.68e-05	0.000784	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—UGT1A1—hematologic cancer	4.57e-05	0.000765	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.48e-05	0.00075	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTO1—hematologic cancer	4.46e-05	0.000747	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CRABP1—hematologic cancer	4.44e-05	0.000744	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC22A1—hematologic cancer	4.44e-05	0.000744	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ARNTL—hematologic cancer	4.42e-05	0.000741	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTO1—hematologic cancer	4.4e-05	0.000737	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALOX5—hematologic cancer	4.33e-05	0.000725	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.33e-05	0.000725	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CA9—hematologic cancer	4.3e-05	0.000721	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACP5—hematologic cancer	4.3e-05	0.000721	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK2—hematologic cancer	4.29e-05	0.000719	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR2—hematologic cancer	4.25e-05	0.000712	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NUP98—hematologic cancer	4.19e-05	0.000703	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—UGT1A1—hematologic cancer	4.19e-05	0.000702	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—hematologic cancer	4.18e-05	0.000701	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—UGT1A1—hematologic cancer	4.13e-05	0.000692	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ADCY7—hematologic cancer	4.07e-05	0.000682	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOA3—hematologic cancer	4.07e-05	0.000682	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—hematologic cancer	4.06e-05	0.00068	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TERT—hematologic cancer	4.05e-05	0.000679	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH1—hematologic cancer	4.05e-05	0.000678	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NUP214—hematologic cancer	4.04e-05	0.000677	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCC3—hematologic cancer	4e-05	0.00067	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTO1—hematologic cancer	4e-05	0.00067	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—TXN—hematologic cancer	4e-05	0.00067	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCG2—hematologic cancer	3.96e-05	0.000664	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTR—hematologic cancer	3.96e-05	0.000664	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SPHK1—hematologic cancer	3.92e-05	0.000656	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ENO2—hematologic cancer	3.88e-05	0.000651	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK2—hematologic cancer	3.84e-05	0.000643	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTT1—hematologic cancer	3.77e-05	0.000631	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—UGT1A1—hematologic cancer	3.76e-05	0.00063	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SDC1—hematologic cancer	3.68e-05	0.000617	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CRABP1—hematologic cancer	3.66e-05	0.000613	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC22A1—hematologic cancer	3.66e-05	0.000613	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.66e-05	0.000613	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—ATM—hematologic cancer	3.64e-05	0.00061	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—MTR—hematologic cancer	3.63e-05	0.000609	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK4—hematologic cancer	3.63e-05	0.000608	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALOX5—hematologic cancer	3.57e-05	0.000597	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—hematologic cancer	3.53e-05	0.000591	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	3.46e-05	0.000579	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NUP98—hematologic cancer	3.45e-05	0.000579	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ADCY7—hematologic cancer	3.35e-05	0.000562	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOA3—hematologic cancer	3.35e-05	0.000562	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NUP214—hematologic cancer	3.33e-05	0.000558	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCG2—hematologic cancer	3.26e-05	0.000546	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTR—hematologic cancer	3.26e-05	0.000546	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO2—hematologic cancer	3.2e-05	0.000536	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RB1—hematologic cancer	3.15e-05	0.000529	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NQO1—hematologic cancer	3.13e-05	0.000525	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CD44—hematologic cancer	3.13e-05	0.000525	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTT1—hematologic cancer	3.1e-05	0.00052	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	3.1e-05	0.00052	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SDC1—hematologic cancer	3.03e-05	0.000508	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYCS—hematologic cancer	2.96e-05	0.000496	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HSP90AA1—hematologic cancer	2.94e-05	0.000493	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—hematologic cancer	2.77e-05	0.000465	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	2.75e-05	0.00046	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MDM2—hematologic cancer	2.69e-05	0.000451	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—hematologic cancer	2.62e-05	0.000439	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—hematologic cancer	2.61e-05	0.000437	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CD44—hematologic cancer	2.58e-05	0.000432	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NQO1—hematologic cancer	2.58e-05	0.000432	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.53e-05	0.000425	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCB1—hematologic cancer	2.47e-05	0.000414	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—hematologic cancer	2.46e-05	0.000411	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYCS—hematologic cancer	2.44e-05	0.000409	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSP90AA1—hematologic cancer	2.42e-05	0.000406	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—hematologic cancer	2.41e-05	0.000404	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—hematologic cancer	2.4e-05	0.000402	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOR1—hematologic cancer	2.4e-05	0.000402	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	2.4e-05	0.000401	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	2.36e-05	0.000396	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—hematologic cancer	2.34e-05	0.000393	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—hematologic cancer	2.27e-05	0.00038	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	2.2e-05	0.000369	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	2.17e-05	0.000364	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.16e-05	0.000362	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—EP300—hematologic cancer	2.16e-05	0.000361	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTP1—hematologic cancer	2.15e-05	0.00036	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTHFR—hematologic cancer	2.12e-05	0.000355	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—hematologic cancer	2.1e-05	0.000352	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCB1—hematologic cancer	2.04e-05	0.000341	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTM1—hematologic cancer	1.98e-05	0.000331	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR1—hematologic cancer	1.98e-05	0.000331	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAPK3—hematologic cancer	1.93e-05	0.000324	CbGpPWpGaD
Hydroxyurea—Dermatitis—Carmustine—hematologic cancer	1.9e-05	9.59e-05	CcSEcCtD
Hydroxyurea—Vomiting—Alitretinoin—hematologic cancer	1.9e-05	9.59e-05	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—hematologic cancer	1.9e-05	9.58e-05	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—hematologic cancer	1.9e-05	9.58e-05	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—hematologic cancer	1.9e-05	9.58e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisolone—hematologic cancer	1.9e-05	9.57e-05	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—hematologic cancer	1.89e-05	9.56e-05	CcSEcCtD
Hydroxyurea—Headache—Carmustine—hematologic cancer	1.89e-05	9.54e-05	CcSEcCtD
Hydroxyurea—Dyspnoea—Triamcinolone—hematologic cancer	1.89e-05	9.52e-05	CcSEcCtD
Hydroxyurea—Rash—Alitretinoin—hematologic cancer	1.88e-05	9.51e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Dexamethasone—hematologic cancer	1.88e-05	9.51e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Betamethasone—hematologic cancer	1.88e-05	9.51e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Alitretinoin—hematologic cancer	1.88e-05	9.51e-05	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Betamethasone—hematologic cancer	1.88e-05	9.49e-05	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dexamethasone—hematologic cancer	1.88e-05	9.49e-05	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—hematologic cancer	1.88e-05	0.000315	CbGpPWpGaD
Hydroxyurea—Vomiting—Ifosfamide—hematologic cancer	1.88e-05	9.48e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cisplatin—hematologic cancer	1.88e-05	9.47e-05	CcSEcCtD
Hydroxyurea—Headache—Alitretinoin—hematologic cancer	1.87e-05	9.45e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Gemcitabine—hematologic cancer	1.87e-05	9.44e-05	CcSEcCtD
Hydroxyurea—Nausea—Thalidomide—hematologic cancer	1.87e-05	9.42e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Triamcinolone—hematologic cancer	1.86e-05	9.4e-05	CcSEcCtD
Hydroxyurea—Rash—Ifosfamide—hematologic cancer	1.86e-05	9.4e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Ifosfamide—hematologic cancer	1.86e-05	9.39e-05	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—hematologic cancer	1.86e-05	9.39e-05	CcSEcCtD
Hydroxyurea—Dizziness—Irinotecan—hematologic cancer	1.85e-05	9.36e-05	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—hematologic cancer	1.85e-05	9.34e-05	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—hematologic cancer	1.85e-05	9.34e-05	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—hematologic cancer	1.85e-05	9.33e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—hematologic cancer	1.84e-05	9.31e-05	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—hematologic cancer	1.84e-05	9.29e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—FTCD—hematologic cancer	1.84e-05	0.000308	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GMPS—hematologic cancer	1.84e-05	0.000308	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PHYH—hematologic cancer	1.84e-05	0.000308	CbGpPWpGaD
Hydroxyurea—Vomiting—Vincristine—hematologic cancer	1.83e-05	9.24e-05	CcSEcCtD
Hydroxyurea—Anorexia—Betamethasone—hematologic cancer	1.83e-05	9.24e-05	CcSEcCtD
Hydroxyurea—Anorexia—Dexamethasone—hematologic cancer	1.83e-05	9.24e-05	CcSEcCtD
Hydroxyurea—Asthenia—Cisplatin—hematologic cancer	1.83e-05	9.22e-05	CcSEcCtD
Hydroxyurea—Fatigue—Triamcinolone—hematologic cancer	1.82e-05	9.21e-05	CcSEcCtD
Hydroxyurea—Rash—Vincristine—hematologic cancer	1.82e-05	9.17e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Vincristine—hematologic cancer	1.81e-05	9.16e-05	CcSEcCtD
Hydroxyurea—Pain—Triamcinolone—hematologic cancer	1.81e-05	9.14e-05	CcSEcCtD
Hydroxyurea—Headache—Vincristine—hematologic cancer	1.8e-05	9.11e-05	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.79e-05	9.06e-05	CcSEcCtD
Hydroxyurea—Nausea—Carmustine—hematologic cancer	1.79e-05	9.05e-05	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—hematologic cancer	1.78e-05	9.01e-05	CcSEcCtD
Hydroxyurea—Vomiting—Irinotecan—hematologic cancer	1.78e-05	9e-05	CcSEcCtD
Hydroxyurea—Vomiting—Mitoxantrone—hematologic cancer	1.78e-05	9e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CG—hematologic cancer	1.78e-05	0.000299	CbGpPWpGaD
Hydroxyurea—Nausea—Alitretinoin—hematologic cancer	1.78e-05	8.96e-05	CcSEcCtD
Hydroxyurea—Convulsion—Prednisone—hematologic cancer	1.77e-05	8.96e-05	CcSEcCtD
Hydroxyurea—Rash—Mitoxantrone—hematologic cancer	1.77e-05	8.93e-05	CcSEcCtD
Hydroxyurea—Rash—Irinotecan—hematologic cancer	1.77e-05	8.93e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Mitoxantrone—hematologic cancer	1.77e-05	8.92e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Irinotecan—hematologic cancer	1.77e-05	8.92e-05	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—hematologic cancer	1.76e-05	8.91e-05	CcSEcCtD
Hydroxyurea—Headache—Mitoxantrone—hematologic cancer	1.76e-05	8.87e-05	CcSEcCtD
Hydroxyurea—Headache—Irinotecan—hematologic cancer	1.76e-05	8.87e-05	CcSEcCtD
Hydroxyurea—Nausea—Ifosfamide—hematologic cancer	1.75e-05	8.86e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MTHFR—hematologic cancer	1.75e-05	0.000293	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Triamcinolone—hematologic cancer	1.74e-05	8.8e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Cisplatin—hematologic cancer	1.74e-05	8.8e-05	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—hematologic cancer	1.74e-05	8.78e-05	CcSEcCtD
Hydroxyurea—Vomiting—Gemcitabine—hematologic cancer	1.74e-05	8.77e-05	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.73e-05	8.75e-05	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—hematologic cancer	1.72e-05	8.7e-05	CcSEcCtD
Hydroxyurea—Rash—Gemcitabine—hematologic cancer	1.72e-05	8.7e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Gemcitabine—hematologic cancer	1.72e-05	8.69e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—hematologic cancer	1.72e-05	8.68e-05	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—hematologic cancer	1.71e-05	8.64e-05	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—hematologic cancer	1.71e-05	8.64e-05	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—hematologic cancer	1.71e-05	8.64e-05	CcSEcCtD
Hydroxyurea—Nausea—Vincristine—hematologic cancer	1.71e-05	8.64e-05	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—hematologic cancer	1.7e-05	8.6e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisolone—hematologic cancer	1.7e-05	8.56e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Dexamethasone—hematologic cancer	1.69e-05	8.53e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Betamethasone—hematologic cancer	1.69e-05	8.53e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—SMPD3—hematologic cancer	1.68e-05	0.000281	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—hematologic cancer	1.67e-05	8.45e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Triamcinolone—hematologic cancer	1.67e-05	8.45e-05	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—hematologic cancer	1.67e-05	8.44e-05	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—hematologic cancer	1.67e-05	8.43e-05	CcSEcCtD
Hydroxyurea—Decreased appetite—Dexamethasone—hematologic cancer	1.67e-05	8.43e-05	CcSEcCtD
Hydroxyurea—Decreased appetite—Betamethasone—hematologic cancer	1.67e-05	8.43e-05	CcSEcCtD
Hydroxyurea—Nausea—Mitoxantrone—hematologic cancer	1.67e-05	8.41e-05	CcSEcCtD
Hydroxyurea—Nausea—Irinotecan—hematologic cancer	1.67e-05	8.41e-05	CcSEcCtD
Hydroxyurea—Infection—Prednisone—hematologic cancer	1.66e-05	8.39e-05	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.66e-05	8.37e-05	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.66e-05	8.37e-05	CcSEcCtD
Hydroxyurea—Fatigue—Betamethasone—hematologic cancer	1.66e-05	8.36e-05	CcSEcCtD
Hydroxyurea—Fatigue—Dexamethasone—hematologic cancer	1.66e-05	8.36e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CREBBP—hematologic cancer	1.65e-05	0.000277	CbGpPWpGaD
Hydroxyurea—Chills—Epirubicin—hematologic cancer	1.65e-05	8.34e-05	CcSEcCtD
Hydroxyurea—Pain—Dexamethasone—hematologic cancer	1.64e-05	8.29e-05	CcSEcCtD
Hydroxyurea—Pain—Betamethasone—hematologic cancer	1.64e-05	8.29e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Prednisone—hematologic cancer	1.64e-05	8.28e-05	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—hematologic cancer	1.63e-05	8.21e-05	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—hematologic cancer	1.62e-05	8.2e-05	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—hematologic cancer	1.62e-05	8.19e-05	CcSEcCtD
Hydroxyurea—Vomiting—Cisplatin—hematologic cancer	1.62e-05	8.17e-05	CcSEcCtD
Hydroxyurea—Rash—Cisplatin—hematologic cancer	1.61e-05	8.11e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Cisplatin—hematologic cancer	1.6e-05	8.1e-05	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—hematologic cancer	1.6e-05	8.09e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—hematologic cancer	1.6e-05	8.06e-05	CcSEcCtD
Hydroxyurea—Anorexia—Prednisone—hematologic cancer	1.59e-05	8.05e-05	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—hematologic cancer	1.59e-05	8.02e-05	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—hematologic cancer	1.58e-05	7.99e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dexamethasone—hematologic cancer	1.58e-05	7.99e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Betamethasone—hematologic cancer	1.58e-05	7.99e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CD—hematologic cancer	1.57e-05	0.000262	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Triamcinolone—hematologic cancer	1.56e-05	7.87e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALB—hematologic cancer	1.55e-05	0.000259	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—hematologic cancer	1.55e-05	7.8e-05	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—hematologic cancer	1.54e-05	7.8e-05	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TP53—hematologic cancer	1.54e-05	0.000259	CbGpPWpGaD
Hydroxyurea—Dizziness—Etoposide—hematologic cancer	1.54e-05	7.79e-05	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—hematologic cancer	1.53e-05	7.74e-05	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—hematologic cancer	1.53e-05	7.72e-05	CcSEcCtD
Hydroxyurea—Dizziness—Prednisolone—hematologic cancer	1.52e-05	7.68e-05	CcSEcCtD
Hydroxyurea—Asthenia—Triamcinolone—hematologic cancer	1.52e-05	7.67e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Dexamethasone—hematologic cancer	1.52e-05	7.66e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Betamethasone—hematologic cancer	1.52e-05	7.66e-05	CcSEcCtD
Hydroxyurea—Nausea—Cisplatin—hematologic cancer	1.51e-05	7.64e-05	CcSEcCtD
Hydroxyurea—Alopecia—Doxorubicin—hematologic cancer	1.5e-05	7.6e-05	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Epirubicin—hematologic cancer	1.49e-05	7.51e-05	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—hematologic cancer	1.48e-05	7.49e-05	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—hematologic cancer	1.48e-05	7.49e-05	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—hematologic cancer	1.48e-05	7.49e-05	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—hematologic cancer	1.48e-05	7.48e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3R1—hematologic cancer	1.48e-05	0.000248	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Prednisone—hematologic cancer	1.47e-05	7.43e-05	CcSEcCtD
Hydroxyurea—Rash—Etoposide—hematologic cancer	1.47e-05	7.43e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—hematologic cancer	1.47e-05	7.42e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—ASNS—hematologic cancer	1.47e-05	0.000246	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DCK—hematologic cancer	1.47e-05	0.000246	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.47e-05	0.000246	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—hematologic cancer	1.47e-05	0.000246	CbGpPWpGaD
Hydroxyurea—Headache—Etoposide—hematologic cancer	1.46e-05	7.38e-05	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—hematologic cancer	1.45e-05	7.34e-05	CcSEcCtD
Hydroxyurea—Rash—Prednisolone—hematologic cancer	1.45e-05	7.32e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisolone—hematologic cancer	1.45e-05	7.32e-05	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.45e-05	7.31e-05	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—hematologic cancer	1.44e-05	7.3e-05	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—hematologic cancer	1.44e-05	7.28e-05	CcSEcCtD
Hydroxyurea—Headache—Prednisolone—hematologic cancer	1.44e-05	7.28e-05	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—hematologic cancer	1.44e-05	7.27e-05	CcSEcCtD
Hydroxyurea—Leukopenia—Epirubicin—hematologic cancer	1.43e-05	7.24e-05	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—hematologic cancer	1.43e-05	7.22e-05	CcSEcCtD
Hydroxyurea—Dizziness—Triamcinolone—hematologic cancer	1.4e-05	7.06e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—HDC—hematologic cancer	1.39e-05	0.000233	CbGpPWpGaD
Hydroxyurea—Convulsion—Epirubicin—hematologic cancer	1.39e-05	7.01e-05	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—hematologic cancer	1.39e-05	7.01e-05	CcSEcCtD
Hydroxyurea—Nausea—Etoposide—hematologic cancer	1.39e-05	7e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—hematologic cancer	1.38e-05	6.96e-05	CcSEcCtD
Hydroxyurea—Asthenia—Betamethasone—hematologic cancer	1.38e-05	6.95e-05	CcSEcCtD
Hydroxyurea—Asthenia—Dexamethasone—hematologic cancer	1.38e-05	6.95e-05	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—hematologic cancer	1.38e-05	6.95e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—hematologic cancer	1.37e-05	6.92e-05	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—hematologic cancer	1.37e-05	6.92e-05	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—hematologic cancer	1.37e-05	6.91e-05	CcSEcCtD
Hydroxyurea—Nausea—Prednisolone—hematologic cancer	1.37e-05	6.9e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CB—hematologic cancer	1.37e-05	0.000229	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CREBBP—hematologic cancer	1.36e-05	0.000228	CbGpPWpGaD
Hydroxyurea—Skin disorder—Methotrexate—hematologic cancer	1.36e-05	6.85e-05	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.35e-05	6.84e-05	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—hematologic cancer	1.35e-05	6.8e-05	CcSEcCtD
Hydroxyurea—Vomiting—Triamcinolone—hematologic cancer	1.35e-05	6.79e-05	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—hematologic cancer	1.34e-05	6.75e-05	CcSEcCtD
Hydroxyurea—Rash—Triamcinolone—hematologic cancer	1.33e-05	6.74e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Triamcinolone—hematologic cancer	1.33e-05	6.73e-05	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—hematologic cancer	1.33e-05	6.72e-05	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—hematologic cancer	1.33e-05	6.7e-05	CcSEcCtD
Hydroxyurea—Headache—Triamcinolone—hematologic cancer	1.33e-05	6.69e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Prednisone—hematologic cancer	1.32e-05	6.67e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Betamethasone—hematologic cancer	1.31e-05	6.63e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Dexamethasone—hematologic cancer	1.31e-05	6.63e-05	CcSEcCtD
Hydroxyurea—Oedema—Epirubicin—hematologic cancer	1.31e-05	6.6e-05	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—hematologic cancer	1.3e-05	6.56e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PIK3CD—hematologic cancer	1.29e-05	0.000216	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—hematologic cancer	1.28e-05	6.49e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—hematologic cancer	1.28e-05	6.47e-05	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—hematologic cancer	1.28e-05	6.46e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALB—hematologic cancer	1.27e-05	0.000213	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CDA—hematologic cancer	1.27e-05	0.000213	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—hematologic cancer	1.27e-05	6.41e-05	CcSEcCtD
Hydroxyurea—Dizziness—Dexamethasone—hematologic cancer	1.27e-05	6.41e-05	CcSEcCtD
Hydroxyurea—Dizziness—Betamethasone—hematologic cancer	1.27e-05	6.41e-05	CcSEcCtD
Hydroxyurea—Nausea—Triamcinolone—hematologic cancer	1.26e-05	6.35e-05	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.25e-05	6.33e-05	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—hematologic cancer	1.25e-05	6.3e-05	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—hematologic cancer	1.25e-05	6.29e-05	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—hematologic cancer	1.25e-05	6.29e-05	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—hematologic cancer	1.24e-05	6.27e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—hematologic cancer	1.23e-05	6.22e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—hematologic cancer	1.23e-05	6.21e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—PC—hematologic cancer	1.22e-05	0.000205	CbGpPWpGaD
Hydroxyurea—Vomiting—Dexamethasone—hematologic cancer	1.22e-05	6.16e-05	CcSEcCtD
Hydroxyurea—Vomiting—Betamethasone—hematologic cancer	1.22e-05	6.16e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PIK3R1—hematologic cancer	1.22e-05	0.000204	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—hematologic cancer	1.21e-05	6.13e-05	CcSEcCtD
Hydroxyurea—Rash—Dexamethasone—hematologic cancer	1.21e-05	6.11e-05	CcSEcCtD
Hydroxyurea—Rash—Betamethasone—hematologic cancer	1.21e-05	6.11e-05	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—hematologic cancer	1.21e-05	6.11e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Dexamethasone—hematologic cancer	1.21e-05	6.11e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Betamethasone—hematologic cancer	1.21e-05	6.11e-05	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.21e-05	6.09e-05	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—hematologic cancer	1.2e-05	6.08e-05	CcSEcCtD
Hydroxyurea—Headache—Betamethasone—hematologic cancer	1.2e-05	6.07e-05	CcSEcCtD
Hydroxyurea—Headache—Dexamethasone—hematologic cancer	1.2e-05	6.07e-05	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—hematologic cancer	1.2e-05	6.07e-05	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—hematologic cancer	1.2e-05	6.06e-05	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—hematologic cancer	1.19e-05	6.03e-05	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—hematologic cancer	1.19e-05	5.99e-05	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—hematologic cancer	1.18e-05	5.98e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.18e-05	0.000198	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GBA—hematologic cancer	1.18e-05	0.000198	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—hematologic cancer	1.18e-05	0.000198	CbGpPWpGaD
Hydroxyurea—Skin disorder—Doxorubicin—hematologic cancer	1.18e-05	5.93e-05	CcSEcCtD
Hydroxyurea—Dyspnoea—Epirubicin—hematologic cancer	1.17e-05	5.89e-05	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—hematologic cancer	1.16e-05	5.87e-05	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—hematologic cancer	1.15e-05	5.82e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—hematologic cancer	1.15e-05	5.81e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—hematologic cancer	1.15e-05	5.81e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Prednisone—hematologic cancer	1.14e-05	5.78e-05	CcSEcCtD
Hydroxyurea—Nausea—Dexamethasone—hematologic cancer	1.14e-05	5.76e-05	CcSEcCtD
Hydroxyurea—Nausea—Betamethasone—hematologic cancer	1.14e-05	5.76e-05	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—hematologic cancer	1.14e-05	5.74e-05	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.13e-05	5.7e-05	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—hematologic cancer	1.13e-05	5.69e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—EP300—hematologic cancer	1.13e-05	0.000188	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—hematologic cancer	1.12e-05	0.000188	CbGpPWpGaD
Hydroxyurea—Constipation—Epirubicin—hematologic cancer	1.12e-05	5.65e-05	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—hematologic cancer	1.12e-05	5.65e-05	CcSEcCtD
Hydroxyurea—Dizziness—Prednisone—hematologic cancer	1.11e-05	5.58e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—hematologic cancer	1.1e-05	5.58e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—MTAP—hematologic cancer	1.08e-05	0.000181	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—hematologic cancer	1.08e-05	5.45e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—hematologic cancer	1.08e-05	5.44e-05	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—hematologic cancer	1.08e-05	5.43e-05	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—hematologic cancer	1.06e-05	5.38e-05	CcSEcCtD
Hydroxyurea—Vomiting—Prednisone—hematologic cancer	1.06e-05	5.37e-05	CcSEcCtD
Hydroxyurea—Rash—Prednisone—hematologic cancer	1.05e-05	5.32e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—hematologic cancer	1.05e-05	5.32e-05	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—hematologic cancer	1.05e-05	5.31e-05	CcSEcCtD
Hydroxyurea—Headache—Prednisone—hematologic cancer	1.05e-05	5.29e-05	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.04e-05	5.27e-05	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—hematologic cancer	1.04e-05	5.27e-05	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—hematologic cancer	1.03e-05	5.22e-05	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—hematologic cancer	1.03e-05	5.22e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—hematologic cancer	1.03e-05	5.22e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—hematologic cancer	1.03e-05	5.2e-05	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—hematologic cancer	1e-05	5.06e-05	CcSEcCtD
Hydroxyurea—Feeling abnormal—Doxorubicin—hematologic cancer	9.97e-06	5.03e-05	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—hematologic cancer	9.93e-06	5.01e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PTEN—hematologic cancer	9.71e-06	0.000163	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FHL2—hematologic cancer	9.64e-06	0.000162	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—hematologic cancer	9.63e-06	4.86e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—hematologic cancer	9.56e-06	4.83e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—hematologic cancer	9.56e-06	4.83e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—AGRN—hematologic cancer	9.46e-06	0.000158	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—hematologic cancer	9.38e-06	4.74e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—EP300—hematologic cancer	9.26e-06	0.000155	CbGpPWpGaD
Hydroxyurea—Dizziness—Methotrexate—hematologic cancer	9.24e-06	4.67e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—HMMR—hematologic cancer	8.96e-06	0.00015	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH2—hematologic cancer	8.96e-06	0.00015	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Epirubicin—hematologic cancer	8.95e-06	4.52e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—hematologic cancer	8.91e-06	4.5e-05	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—hematologic cancer	8.88e-06	4.49e-05	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—hematologic cancer	8.81e-06	4.45e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—hematologic cancer	8.8e-06	4.44e-05	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—hematologic cancer	8.75e-06	4.42e-05	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—hematologic cancer	8.68e-06	4.38e-05	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—hematologic cancer	8.65e-06	4.37e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—ARNTL—hematologic cancer	8.43e-06	0.000141	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—hematologic cancer	8.32e-06	0.000139	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—hematologic cancer	8.31e-06	4.2e-05	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—hematologic cancer	8.3e-06	4.19e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—hematologic cancer	8.28e-06	4.18e-05	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—hematologic cancer	8.24e-06	4.16e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—hematologic cancer	8.24e-06	4.16e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—ACP5—hematologic cancer	8.2e-06	0.000137	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA9—hematologic cancer	8.2e-06	0.000137	CbGpPWpGaD
Hydroxyurea—Headache—Epirubicin—hematologic cancer	8.19e-06	4.14e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—NCOR2—hematologic cancer	8.09e-06	0.000136	CbGpPWpGaD
Hydroxyurea—Dizziness—Doxorubicin—hematologic cancer	8e-06	4.04e-05	CcSEcCtD
Hydroxyurea—Nausea—Epirubicin—hematologic cancer	7.77e-06	3.92e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—IDH1—hematologic cancer	7.71e-06	0.000129	CbGpPWpGaD
Hydroxyurea—Vomiting—Doxorubicin—hematologic cancer	7.69e-06	3.88e-05	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—hematologic cancer	7.63e-06	3.85e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.62e-06	0.000128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.62e-06	0.000128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TXN—hematologic cancer	7.62e-06	0.000128	CbGpPWpGaD
Hydroxyurea—Dermatitis—Doxorubicin—hematologic cancer	7.62e-06	3.85e-05	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—hematologic cancer	7.58e-06	3.83e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—SPHK1—hematologic cancer	7.46e-06	0.000125	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—hematologic cancer	7.19e-06	3.63e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.17e-06	0.00012	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC22A1—hematologic cancer	6.97e-06	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CRABP1—hematologic cancer	6.97e-06	0.000117	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—hematologic cancer	6.85e-06	0.000115	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—hematologic cancer	6.8e-06	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.79e-06	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NUP98—hematologic cancer	6.58e-06	0.00011	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.39e-06	0.000107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.39e-06	0.000107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NUP214—hematologic cancer	6.34e-06	0.000106	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.21e-06	0.000104	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTR—hematologic cancer	6.21e-06	0.000104	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—hematologic cancer	6.09e-06	0.000102	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.91e-06	9.9e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SDC1—hematologic cancer	5.78e-06	9.68e-05	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—hematologic cancer	5.6e-06	9.38e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CD44—hematologic cancer	4.91e-06	8.23e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NQO1—hematologic cancer	4.91e-06	8.23e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYCS—hematologic cancer	4.65e-06	7.79e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.62e-06	7.74e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.1e-06	6.86e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.88e-06	6.5e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.76e-06	6.31e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.76e-06	6.31e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.33e-06	5.57e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.8e-06	4.68e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.59e-06	4.34e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.46e-06	4.12e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALB—hematologic cancer	2.43e-06	4.06e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.32e-06	3.89e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.14e-06	3.59e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—hematologic cancer	1.85e-06	3.1e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—hematologic cancer	1.77e-06	2.96e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.31e-06	2.19e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—hematologic cancer	1.07e-06	1.79e-05	CbGpPWpGaD
